Skip to main content
BBNX logo
BBNX
(NASDAQ)
Beta Bionics, Inc.
$13.67-- (--)
Loading... - Market loading

Beta Bionics (BBNX) Stock Price & Financial Analysis

Beta Bionics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.50 - $13.94
52-Week High$32.71
52-Week Low$8.80
Open$13.67
Volume864.21K
Average Volume (3M)901.06K
Market Cap607.44M
Shares Outstanding44.44M
Price to Sales (P/S)5.51
Price to Book (P/B)2.24
EV/EBITDA-8.18
Revenue (TTM)110.24M
Net Income (TTM)-66.44M
Free Cash Flow (TTM)-61.12M
EPS (TTM)$-1.55
Profit Margin-60.27%
Operating Margin-70.13%
Return on Equity (ROE)-24.49%
Debt to Equity0.03
50-Day MA$11.79
200-Day MA$18.40
52-Week Change-13.48%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Beta Bionics

What is the current stock price for BBNX?

As of the latest trading session, BBNX stock trades at $13.67. The 52-week range is $8.80–$32.71, with a day range of $13.50–$13.94.

What is the P/E ratio for BBNX?

The P/E ratio (Price-to-Earnings) for BBNX is shown in the Key Statistics section. This valuation metric helps compare Beta Bionics, Inc. to industry peers.

Does BBNX pay dividends?

Beta Bionics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BBNX?

Based on 9 analysts, the consensus for BBNX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BBNX?

Beta Bionics's market capitalization is $607.4M, classifying it as a small-cap company. Beta Bionics operates in the Healthcare sector within the Medical Devices industry.